摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

S-(+)-norlaudanosine*HCl | 54417-52-6

中文名称
——
中文别名
——
英文名称
S-(+)-norlaudanosine*HCl
英文别名
(S)-(+)-norlaudanosine hydrochloride;(S)-tetrahydropapaverine hydrochloride;(S)-(+)-norlaudanosine;(S)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3.4-tetrahydroisoquinoline hydrochloride;(S)-6,7-dimethoxy-1-veratryl-1,2,3,4-tetrahydro-isoquinoline; hydrochloride;(S)-6,7-Dimethoxy-1-veratryl-1,2,3,4-tetrahydro-isochinolin; Hydrochlorid;(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-ium;chloride
S-(+)-norlaudanosine*HCl化学式
CAS
54417-52-6
化学式
C20H25NO4*ClH
mdl
——
分子量
379.884
InChiKey
VMPLLPIDRGXFTQ-NTISSMGPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.57
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    49
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • 1,2,3,4-tetrahydroisoquinoline derivative and its use as orexin receptor antagonist
    申请人:Actelion Pharmaceuticals Ltd.
    公开号:EP2402322A1
    公开(公告)日:2012-01-04
    The invention relates to the compound (R)-2-[(S)-1-(3,4-Dimethoxy-benzyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]-N-isopropyl-2-phenyl-acetamide; and to its use as active ingredient in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compound, pharmaceutical compositions containing the compound and methods of treatment comprising administration of said compound to a human being.
    该发明涉及化合物(R)-2-[(S)-1-(3,4-二甲氧基苄基)-6,7-二甲氧基-3,4-二氢-1H-异喹啉-2-基]-N-异丙基-2-苯乙酰胺;以及其作为制备药物组合物中的活性成分的用途。该发明还涉及相关方面,包括制备该化合物的过程、含有该化合物的药物组合物和包括将该化合物给予人体的治疗方法。
  • A novel asymmetric reduction of imines with chiral sodium triacyloxyborohydrides
    作者:Koichiro Yamada、Mikio Takeda、Takeo Iwakuma
    DOI:10.1016/s0040-4039(01)91331-0
    日期:1981.1
    There has been described a novel and convenient synthesis of optically active alkaloids by the asymmetric reduction of cyclic imines using the chiral sodium triacyloxyborohydrides, easily prepared from the reaction of NaBH4 and N-acyl L-prolines.
    已经描述了使用手性三酰氧基硼氢化钠通过不对称还原环状亚胺来新颖且方便地合成旋光生物碱,所述手性三酰氧基硼氢化钠易于从NaBH 4和N-酰基L-脯氨酸的反应制备。
  • Organocatalytic Enantioselective Pictet–Spengler Approach to Biologically Relevant 1-Benzyl-1,2,3,4-Tetrahydroisoquinoline Alkaloids
    作者:Andrea Ruiz-Olalla、Martien A. Würdemann、Martin J. Wanner、Steen Ingemann、Jan H. van Maarseveen、Henk Hiemstra
    DOI:10.1021/acs.joc.5b00509
    日期:2015.5.15
    A general procedure for the synthesis of 1-benzyl-1,2,3,4-tetrahydroisoquinolines was developed, based on organocatalytic, regio- and enantioselective Pictet-Spengler reactions (86-92% ee) of N-(o-nitrophenylsulfenyl)-2-arylethyl-amines with arylacetaldehydes. The presence of the o-nitrophenylsulfenyl group, together with the MOM-protection in the catechol part of the tetrahydroisoquinoline ring system, appeared to be a productive combination. To demonstrate the versatility of this approach, 10 biologically and pharmaceutically relevant alkaloids were prepared using (R)-TRIP as the chiral catalyst: (R)-norcoclaurine, (R)-coclaurine, (R)-norreticuline, (R)-reticuline, (R)-trimemetoquinol, (R)-armepavine, (R)-norprotosinomenine, (R)-protosinomenine, (R)-laudanosine, and (R)-5-methoxylaudanosine.
  • Yamada, Koichiro; Takeda, Mikio; Iwakuma, Takeo, Journal of the Chemical Society. Perkin transactions I, 1983, # 2, p. 265 - 270
    作者:Yamada, Koichiro、Takeda, Mikio、Iwakuma, Takeo
    DOI:——
    日期:——
查看更多